480 related articles for article (PubMed ID: 8033885)
1. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
[TBL] [Abstract][Full Text] [Related]
2. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate.
Wilcox RA; Whitham EM; Liu C; Potter BV; Nahorski SR
FEBS Lett; 1993 Dec; 336(2):267-71. PubMed ID: 8262243
[TBL] [Abstract][Full Text] [Related]
3. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.
Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV
FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165
[TBL] [Abstract][Full Text] [Related]
4. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
[TBL] [Abstract][Full Text] [Related]
5. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
[TBL] [Abstract][Full Text] [Related]
6. 3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition.
Safrany ST; Wilcox RA; Liu C; Potter BV; Nahorski SR
Eur J Pharmacol; 1992 Jul; 226(3):265-72. PubMed ID: 1330634
[TBL] [Abstract][Full Text] [Related]
7. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
Safrany ST; Wojcikiewicz RJ; Strupish J; McBain J; Cooke AM; Potter BV; Nahorski SR
Mol Pharmacol; 1991 Jun; 39(6):754-61. PubMed ID: 1646949
[TBL] [Abstract][Full Text] [Related]
8. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
[TBL] [Abstract][Full Text] [Related]
9. Binding and activity of the nine possible regioisomers of myo-inositol tetrakisphosphate at the inositol 1,4,5-trisphosphate receptor.
Burford NT; Nahorski SR; Chung SK; Chang YT; Wilcox RA
Cell Calcium; 1997 Apr; 21(4):301-10. PubMed ID: 9160166
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase.
Van Dijken P; Lammers AA; Ozaki S; Potter BV; Erneux C; Van Haastert PJ
Eur J Biochem; 1994 Dec; 226(2):561-6. PubMed ID: 8001571
[TBL] [Abstract][Full Text] [Related]
11. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
[TBL] [Abstract][Full Text] [Related]
12. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S
Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676
[TBL] [Abstract][Full Text] [Related]
13. The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle.
Foster PS; Hogan SP; Hansbro PM; O'Brien R; Potter BV; Ozaki S; Denborough MA
Eur J Biochem; 1994 Jun; 222(3):955-64. PubMed ID: 8026506
[TBL] [Abstract][Full Text] [Related]
14. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
[TBL] [Abstract][Full Text] [Related]
15. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
[TBL] [Abstract][Full Text] [Related]
16. Interactions between inositol tris- and tetrakis-phosphates. Effects on intracellular Ca2+ mobilization in SH-SY5Y cells.
Gawler DJ; Potter BV; Gigg R; Nahorski SR
Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):163-7. PubMed ID: 1645528
[TBL] [Abstract][Full Text] [Related]
17. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
[TBL] [Abstract][Full Text] [Related]
18. Inositol 1,3,4,5-tetrakisphosphate-induced release of intracellular Ca2+ in SH-SY5Y neuroblastoma cells.
Gawler DJ; Potter BV; Nahorski SR
Biochem J; 1990 Dec; 272(2):519-24. PubMed ID: 2176465
[TBL] [Abstract][Full Text] [Related]
19. Inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate are inhibitors of the soluble inositol 1,3,4,5-tetrakisphosphate 3-phosphatase and the inositol 1,4,5-trisphosphate/1,3,4,5-tetrakisphosphate 5-phosphatase from pig brain.
Höer A; Oberdisse E
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):219-24. PubMed ID: 1652939
[TBL] [Abstract][Full Text] [Related]
20. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor.
Safrany ST; Sawyer DA; Nahorski SR; Potter BV
Chirality; 1992; 4(7):415-22. PubMed ID: 1334423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
